October 13, 2022
LexaGene announces that it has received an indication that a major biopharma company intends to purchase its technology.
September 1, 2022
LexaGene announces that it has entered into a purchase agreement with a veterinary hospital in southern California.
August 29, 2022
LexaGene announces the MiQLab® System can perform the Centers for Disease Control and Prevention (CDC) Monkeypox real-time PCR test.
August 24, 2022
LexaGene has successfully configured the MiQLab System to use isothermal chemistry for individual pathogen detection in as soon as 30 minutes.
August 17, 2022
LexaGene announces the start of an evaluation of a gastrointestinal (GI) pathogen panel.
August 10, 2022
LexaGene has shortened the time the MiQLab® System needs to report a result by ~35%.
July 29, 2022
LexaGene has filed financial statements and granted incentive equity awards to employees.
July 27, 2022
LexaGene provides a summary of preliminary data collected during a clinical validation study.
July 12, 2022
LexaGene continues to make progress on Annual Financial Filings.
July 5, 2022
UC Davis Professor Jane Sykes presents a webinar on a multi-center study using the MiQLab to diagnose urinary tract infections
For Marketing inquiries, please email:
info@lexagene.com
800-215-1824